Ubiquitin-specific protease 25 regulates TLR4-dependent innate immune responses through deubiquitination of the adaptor protein TRAF3

Science Signaling

Volumn 6, Issue 275, 2013, Pages

  Zhong, Bo ^a   Liu, Xikui ^a   Wang, Xiaohu ^a   Liu, Xindong ^a   Li, Hongxiu ^a   Darnay, Bryant G ^a   Lin, Xin ^a   Sun, Shao Cong ^a   Dong, Chen ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF APOPTOSIS PROTEIN 2; INTERFERON REGULATORY FACTOR 3; MITOGEN ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 3; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UBIQUITIN PROTEIN LIGASE; UBIQUITIN SPECIFIC PROTEASE 25; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEPTIC SHOCK; SIGNAL TRANSDUCTION; UBIQUITINATION;

ANIMALS; IMMUNITY, INNATE; INTERFERON-ALPHA; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROTEOLYSIS; SHOCK, SEPTIC; TNF RECEPTOR-ASSOCIATED FACTOR 3; TNF RECEPTOR-ASSOCIATED FACTOR 6; TOLL-LIKE RECEPTOR 4; UBIQUITIN THIOLESTERASE; UBIQUITINATION;

EID: 84877973388     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2003708     Document Type: Article

References (41)

1. S. Akira, S. Uematsu, O. Takeuchi, Pathogen recognition and innate immunity. Cell 124, 783-801 (2006).
2. R. Medzhitov, Recognition of microorganisms and activation of the immune response. Nature 449, 819-826 (2007).
3. T. Kawai, S. Akira, The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat. Immunol. 11, 373-384 (2010).
4. A. Poltorak, X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, B. Beutler, Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 282, 2085-2088 (1998).
5. A. Ozinsky, D. M. Underhill, J. D. Fontenot, A. M. Hajjar, K. D. Smith, C. B. Wilson, L. Schroeder, A. Aderem, The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. U.S.A. 97, 13766-13771 (2000).
6. L. Alexopoulou, V. Thomas,M. Schnare, Y. Lobet, J. Anguita, R. T. Schoen, R. Medzhitov, E. Fikrig, R. A. Flavell, Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat. Med. 8, 878-884 (2002).
7. L. Alexopoulou, A. C. Holt, R. Medzhitov, R. A. Flavell, Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413, 732-738 (2001).
8. F. Heil, H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirschning, S. Akira, G. Lipford, H. Wagner, S. Bauer, Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303, 1526-1529 (2004).
9. H. Hemmi, O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, S. Akira, A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
10. T. Kawai, S. Akira, Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34, 637-650 (2011).
11. A. Iwasaki, R. Medzhitov, Regulation of adaptive immunity by the innate immune system. Science 327, 291-295 (2010).
12. B. Skaug, X. Jiang, Z. J. Chen, The role of ubiquitin in NF-κB regulatory pathways. Annu. Rev. Biochem. 78, 769-796 (2009).
13. H. Häcker, V. Redecke, B. Blagoev, I. Kratchmarova, L. C. Hsu, G. G. Wang, M. P. Kamps, E. Raz, H. Wagner, G. Häcker, M. Mann, M. Karin, Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439, 204-207 (2006).
14. G. Oganesyan, S. K. Saha, B. Guo, J. Q. He, A. Shahangian, B. Zarnegar, A. Perry, G. Cheng, Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439, 208-211 (2006).
15. P. H. Tseng, A. Matsuzawa, W. Zhang, T. Mino, D. A. Vignali, M. Karin, Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat. Immunol. 11, 70-75 (2010).
16. N. Kayagaki, Q. Phung, S. Chan, R. Chaudhari, C. Quan, K. M. O'Rourke, M. Eby, E. Pietras, G. Cheng, J. F. Bazan, Z. Zhang, D. Arnott, V. M. Dixit, DUBA: A deubiquitinase that regulates type I interferon production. Science 318, 1628-1632 (2007).
17. D. Komander, M. J. Clague, S. Urbé, Breaking the chains: Structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 10, 550-563 (2009).
18. F. E. Reyes-Turcu, K. H. Ventii, K. D.Wilkinson, Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes. Annu. Rev. Biochem. 78, 363-397 (2009).
19. S. M. Nijman, M. P. Luna-Vargas, A. Velds, T. R. Brummelkamp, A. M. Dirac, T. K. Sixma, R. Bernards, A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786 (2005).
20. S. C. Sun, Deubiquitylation and regulation of the immune response. Nat. Rev. Immunol. 8, 501-511 (2008).
21. D. L. Boone, E. E. Turer, E. G. Lee, R. C. Ahmad, M. T. Wheeler, C. Tsui, P. Hurley, M. Chien, S. Chai, O. Hitotsumatsu, E. McNally, C. Pickart, A. Ma, The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5, 1052-1060 (2004).
22. N. Shembade, A. Ma, E. W. Harhaj, Inhibition of NF-κB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327, 1135-1139 (2010).
23. Y. Y. Wang, L. Li, K. J. Han, Z. Zhai, H. B. Shu, A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-κB and ISRE and IFN-β promoter. FEBS Lett. 576, 86-90 (2004).
24. I. E.Wertz, K. M. O'Rourke, H. Zhou, M. Eby, L. Aravind, S. Seshagiri, P.Wu, C. Wiesmann, R. Baker, D. L. Boone, A. Ma, E. V. Koonin, V. M. Dixit, De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-κB signalling. Nature 430, 694-699 (2004).
25. J. Zhang, B. Stirling, S. T. Temmerman, C. A. Ma, I. J. Fuss, J. M. Derry, A. Jain, Impaired regulation of NF-κB and increased susceptibility to colitis-associated tumorigenesis in CYLD-deficient mice. J. Clin. Invest. 116, 3042 - 3049 (2006).
26. M. Zhang, X. Wu, A. J. Lee, W. Jin, M. Chang, A. Wright, T. Imaizumi, S. C. Sun, Regulation of IκB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J. Biol. Chem. 283, 18621-18626 (2008).
27. S. Li, H. Zheng, A. P. Mao, B. Zhong, Y. Li, Y. Liu, Y. Gao, Y. Ran, P. Tien, H. B. Shu, Regulation of virus-triggered signaling by OTUB1- and OTUB2-mediated deubiquitination of TRAF3 and TRAF6. J. Biol. Chem. 285, 4291-4297 (2010).
28. B. Zhong, X. Liu, X. Wang, S. H. Chang, X. Liu, A. Wang, J. M. Reynolds, C. Dong, Negative regulation of IL-17-mediated signaling and inflammation by the ubiquitin-specific protease USP25. Nat. Immunol. 13, 1110-1117 (2012).
29. A. Denuc, A. Bosch-Comas, R. Gonzàlez-Duarte, G. Marfany, The UBA-UIM domains of the USP25 regulate the enzyme ubiquitination state and modulate substrate recognition. PLoS One 4, e5571 (2009).
30. A. P. Mao, S. Li, B. Zhong, Y. Li, J. Yan, Q. Li, C. Teng, H. B. Shu, Virus-triggered ubiquitination of TRAF3/6 by cIAP1/2 is essential for induction of interferon-β (IFN-β) and cellular antiviral response. J. Biol. Chem. 285, 9470-9476 (2010).
31. H. An, C. Qian, X. Cao, Regulation of Toll-like receptor signaling in the innate immunity. Sci. China Life Sci. 53, 34-43 (2010).
32. E. Meulmeester, M. Kunze, H. H. Hsiao, H. Urlaub, F. Melchior, Mechanism and consequences for paralog-specific sumoylation of ubiquitin-specific protease 25. Mol. Cell 30, 610-619 (2008).
33. M. Triantafilou, K. Miyake, D. T. Golenbock, K. Triantafilou, Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 115, 2603-2611 (2002).
34. J. C. Kagan, T. Su, T. Horng, A. Chow, S. Akira, R. Medzhitov, TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-b. Nat. Immunol. 9, 361-368 (2008).
35. J. C. Kagan, Signaling organelles of the innate immune system. Cell 151, 1168-1178 (2012).
36. J. P. Alameda, R. Moreno-Maldonado, M. Navarro, A. Bravo, A. Ramírez, A. Page, J. L. Jorcano, M. J. Fernández-Aceñero, M. L. Casanova, An inactivating CYLD mutation promotes skin tumor progression by conferring enhanced proliferative, survival and angiogenic properties to epidermal cancer cells. Oncogene 29, 6522-6532 (2010).
37. S. G. Hymowitz, I. E.Wertz, A20: From ubiquitin editing to tumour suppression. Nat. Rev. Cancer 10, 332-341 (2010).
38. A. Bosch-Comas, K. Lindsten, R. Gonzàlez-Duarte, M. G. Masucci, G. Marfany, The ubiquitin-specific protease USP25 interacts with three sarcomeric proteins. Cell. Mol. Life Sci. 63, 723-734 (2006).
39. B. Zhong, L. Zhang, C. Lei, Y. Li, A. P. Mao, Y. Yang, Y. Y. Wang, X. L. Zhang, H. B. Shu, The ubiquitin ligase RNF5 regulates antiviral responses by mediating degradation of the adaptor protein MITA. Immunity 30, 397-407 (2009).
40. M. Chang, W. Jin, S. C. Sun, Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production. Nat. Immunol. 10, 1089-1095 (2009).
41. F. Martinon, X. Chen, A. H. Lee, L. H. Glimcher, TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat. Immunol. 11, 411-418 (2010).